What’s Happening With Novavax Stock?
- Wednesday, January 13, 2021, 12:45
- Market
- Add a comment
Vaccine developer Novavax (NASDAQ: NVAX) is seen as a key player in the Coronavirus vaccine space. Here’s a quick overview of what has been happening with the company over the last few weeks. Firstly, Novavax initiated a phase 3 study for its Covid-19 vaccine candidate in the U.S. and Mexico…
About the Author
admin123 has written 23544 stories on this site.
